Page last updated: 2024-08-23

1-deoxynojirimycin and Genetic Predisposition

1-deoxynojirimycin has been researched along with Genetic Predisposition in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Barth, JA; Castelli, JP; Hamazaki, T; Lagast, H; Narita, I; Ohashi, T; Sakai, N; Skuban, N1
Hughes, DA; Mehta, A; Thomas, AS1
Lo, SM; McNamara, J; Mistry, PK; Seashore, MR1

Reviews

1 review(s) available for 1-deoxynojirimycin and Genetic Predisposition

ArticleYear
Gaucher disease: haematological presentations and complications.
    British journal of haematology, 2014, Volume: 165, Issue:4

    Topics: 1-Deoxynojirimycin; Anemia; Combined Modality Therapy; Disease Management; Enzyme Replacement Therapy; Gaucher Disease; Genetic Predisposition to Disease; Glucosylceramidase; Glycosphingolipids; Hemorrhagic Disorders; Humans; Inflammation; Lewy Body Disease; Lysosomes; Macrophage Activation; Multiple Myeloma; Parkinson Disease; Splenectomy; Splenomegaly; Thrombocytopenia; Unfolded Protein Response

2014

Trials

1 trial(s) available for 1-deoxynojirimycin and Genetic Predisposition

ArticleYear
Efficacy and safety of migalastat in a Japanese population: a subgroup analysis of the ATTRACT study.
    Clinical and experimental nephrology, 2020, Volume: 24, Issue:2

    Topics: 1-Deoxynojirimycin; Administration, Oral; Adult; alpha-Galactosidase; Fabry Disease; Female; Genetic Predisposition to Disease; Humans; Japan; Male; Middle Aged; Mutation; Prospective Studies; Time Factors; Treatment Outcome

2020

Other Studies

1 other study(ies) available for 1-deoxynojirimycin and Genetic Predisposition

ArticleYear
Misdiagnosis of Niemann-Pick disease type C as Gaucher disease.
    Journal of inherited metabolic disease, 2010, Volume: 33 Suppl 3

    Topics: 1-Deoxynojirimycin; Acid Phosphatase; Biomarkers; Carrier Proteins; Cells, Cultured; Cholesterol Esters; Diagnostic Errors; DNA Mutational Analysis; Enzyme Inhibitors; Enzyme Replacement Therapy; Esterification; Female; Gaucher Disease; Genetic Predisposition to Disease; Glucosylceramidase; Glucosyltransferases; Hepatomegaly; Heterozygote; Hexosaminidases; Humans; Infant; Intracellular Signaling Peptides and Proteins; Isoenzymes; Membrane Glycoproteins; Mutation; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Phenotype; Predictive Value of Tests; Splenomegaly; Tartrate-Resistant Acid Phosphatase; Unnecessary Procedures

2010